285 related articles for article (PubMed ID: 11157622)
1. Aerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertension.
Schenk P; Petkov V; Madl C; Kramer L; Kneussl M; Ziesche R; Lang I
Chest; 2001 Jan; 119(1):296-300. PubMed ID: 11157622
[TBL] [Abstract][Full Text] [Related]
2. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
[TBL] [Abstract][Full Text] [Related]
3. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment of pulmonary hypertension with aerosolized iloprost.
Machherndl S; Kneussl M; Baumgartner H; Schneider B; Petkov V; Schenk P; Lang IM
Eur Respir J; 2001 Jan; 17(1):8-13. PubMed ID: 11307761
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.
Hoeper MM; Olschewski H; Ghofrani HA; Wilkens H; Winkler J; Borst MM; Niedermeyer J; Fabel H; Seeger W
J Am Coll Cardiol; 2000 Jan; 35(1):176-82. PubMed ID: 10636277
[TBL] [Abstract][Full Text] [Related]
7. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
Hoeper MM; Schwarze M; Ehlerding S; Adler-Schuermeyer A; Spiekerkoetter E; Niedermeyer J; Hamm M; Fabel H
N Engl J Med; 2000 Jun; 342(25):1866-70. PubMed ID: 10861321
[TBL] [Abstract][Full Text] [Related]
9. Continuous hemodynamic monitoring in pulmonary hypertensive patients treated with inhaled iloprost.
Fruhwald FM; Kjellström B; Perthold W; Watzinger N; Maier R; Grandjean PA; Klein W
Chest; 2003 Jul; 124(1):351-9. PubMed ID: 12853544
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise.
Blumberg FC; Riegger GA; Pfeifer M
Chest; 2002 May; 121(5):1566-71. PubMed ID: 12006445
[TBL] [Abstract][Full Text] [Related]
11. Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.
Petkov V; Ziesche R; Mosgoeller W; Schenk P; Vonbank K; Stiebellehner L; Raderer M; Brunner C; Kneussl M; Block LH
Thorax; 2001 Sep; 56(9):734-6. PubMed ID: 11514696
[TBL] [Abstract][Full Text] [Related]
12. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group.
Olschewski H; Ghofrani HA; Schmehl T; Winkler J; Wilkens H; Höper MM; Behr J; Kleber FX; Seeger W
Ann Intern Med; 2000 Mar; 132(6):435-43. PubMed ID: 10733442
[TBL] [Abstract][Full Text] [Related]
13. Recovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost.
Olschewski H; Ghofrani HA; Walmrath D; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Intensive Care Med; 1998 Jun; 24(6):631-4. PubMed ID: 9681789
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension.
Stiebellehner L; Petkov V; Vonbank K; Funk G; Schenk P; Ziesche R; Block LH
Chest; 2003 Apr; 123(4):1293-5. PubMed ID: 12684325
[TBL] [Abstract][Full Text] [Related]
15. Sustained improvement of performance and haemodynamics with long-term aerosolised prostacyclin therapy in severe pulmonary hypertension.
Stricker H; Domenighetti G; Fiori G; Mombelli G
Schweiz Med Wochenschr; 1999 Jun; 129(24):923-7. PubMed ID: 10413827
[TBL] [Abstract][Full Text] [Related]
16. Aerosolized iloprost in CREST syndrome related pulmonary hypertension.
Launay D; Hachulla E; Hatron PY; Goullard L; Onimus T; Robin S; Fauchais AL; Queyrel V; Michon-Pasturel U; Hebbar M; Saulnier F; Devulder B
J Rheumatol; 2001 Oct; 28(10):2252-6. PubMed ID: 11669165
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension.
Gessler T; Schmehl T; Hoeper MM; Rose F; Ghofrani HA; Olschewski H; Grimminger F; Seeger W
Eur Respir J; 2001 Jan; 17(1):14-9. PubMed ID: 11307743
[TBL] [Abstract][Full Text] [Related]
18. Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertension.
Halank M; Kolditz M; Opitz C; Hoeffken G; Ewert R
Wien Klin Wochenschr; 2006 Feb; 118(1-2):54-9. PubMed ID: 16489527
[TBL] [Abstract][Full Text] [Related]
19. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM
Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
[TBL] [Abstract][Full Text] [Related]
20. Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease.
Hallioglu O; Dilber E; Celiker A
Am J Cardiol; 2003 Oct; 92(8):1007-9. PubMed ID: 14556887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
